What is considered microdosing in GLP-1 medications?
•
4 min read
According to a survey by the healthcare software company Tebra, 36% of GLP-1 users have reported microdosing their medication. Microdosing in GLP-1 medications is the practice of intentionally taking a smaller or less frequent dose than the standard therapeutic amount, a trend driven by the desire to minimize side effects, lower costs, and ease into treatment.
